Search

Your search keyword '"Kini, Annapoorna S."' showing total 62 results

Search Constraints

Start Over You searched for: Author "Kini, Annapoorna S." Remove constraint Author: "Kini, Annapoorna S." Database Academic Search Index Remove constraint Database: Academic Search Index
62 results on '"Kini, Annapoorna S."'

Search Results

1. A mobile application for STEMI care optimization: Pilot implementation project report.

2. Fibrous Cap Thickness by Optical Coherence Tomography In Vivo.

3. Intracoronary Imaging, Cholesterol Efflux, and Transcriptomes After Intensive Statin Treatment: The YELLOW II Study.

4. Impact of Hemodynamic Support With Impella 2.5 Versus Intra-Aortic Balloon Pump on Prognostically Important Clinical Outcomes in Patients Undergoing High-Risk Percutaneous Coronary Intervention (from the PROTECT II Randomized Trial).

6. Changes in plaque lipid content after short-term intensive versus standard statin therapy: the YELLOW trial (reduction in yellow plaque by aggressive lipid-lowering therapy).

7. Changes in Plaque Lipid Content After Short-Term Intensive Versus Standard Statin Therapy.

8. Stenting of complex lesions: an overview.

9. Thrombolysis In Myocardial Infarction (TIMI) Risk Score and Mortality in Patients With Advanced Chronic Kidney Disease and on Dialysis

10. Relation of High-Density Lipoprotein Cholesterol to Mortality After Percutaneous Coronary Interventions in Patients With Low-Density Lipoprotein <70 mg/dl

11. Comparison of Coronary Flow Reserve and Fractional Flow Reserve in Patients With Versus Without Diabetes Mellitus and Having Elective Percutaneous Coronary Intervention and Abciximab Therapy (from the PREDICT Trial)

12. Effectiveness of the Stent Pull-Back Technique for Nonaorto Ostial Coronary Narrowings

13. Results of repeat balloon valvuloplasty for treatment of aortic stenosis in patients aged 59 to 104 years

14. Anemia is an independent predictor of mortality after percutaneous coronary intervention

15. Correlation of postpercutaneous coronary intervention creatine kinase-MB and troponin I elevation in predicting mid-term mortality

16. Prediction of outcome after percutaneous coronary intervention for the acute coronary syndrome

17. Postprocedure chest pain after coronary stenting: implications on clinical restenosis

18. Effectiveness of tirofiban, eptifibatide, and abciximab in minimizing myocardial necrosis during percutaneous coronary intervention (TEAM pilot study)* <FN ID="FN1"><NO>*</NO>There is no conflict of interest either real or perceived of any author in the publication of this manuscript.</FN>

19. Changing trends in incidence and predictors of radiographic contrast nephropathy after percutaneous coronary intervention with use of fenoldopam

20. A risk stratification scheme for selection of a glycoprotein IIb/IIIa inhibitor during percutaneous coronary intervention based on clinical and angiographic criteria.

21. Mortality After Procedural or Spontaneous Myocardial Infarction.

22. Transcatheter Aortic Valve Replacement: Current Status and Future Indications.

26. Statins, atherosclerosis regression and HDL: Insights from within the plaque.

27. Clustering of Metabolic Abnormalities Among Obese Patients and Mortality After Percutaneous Coronary Intervention

28. Catheter Selection for Coronary Angiography and Intervention in Anomalous Right Coronary Arteries.

29. Rotational Atherectomy for the Management of Undilatable In-Stent Restenosis with Single or Multiple Stent Layers.

30. Impact of diabetes mellitus on clinical outcomes after first episode in-stent restenosis PCI: Results from a large registry.

31. Relationship between high shear stress and OCT-verified thin-cap fibroatheroma in patients with coronary artery disease.

32. 2-Year Outcomes After Stenting of Lipid-Rich and Nonrich Coronary Plaques.

33. Ticagrelor With or Without Aspirin After PCI: The TWILIGHT Platelet Substudy.

34. Reduced Leaflet Motion after Transcatheter Aortic-Valve Replacement.

35. Developing a Mobile Application for Global Cardiovascular Education.

36. Efficacy and safety of everolimus and zotarolimus-eluting stents versus first-generation drug-eluting stents in patients with diabetes: A meta-analysis of randomized trials.

37. Acute cholecystitis and myocardial infarction: a case study with coronary involvement.

38. Enhanced neointimal fibroblast, myofibroblast content and altered extracellular matrix composition: Implications in the progression of human peripheral artery restenosis.

39. Coronary Thrombosis and Major Bleeding After PCI With Drug-Eluting Stents: Risk Scores From PARIS.

40. Balancing the Risk of Bleeding and Stroke in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention (from the AVIATOR Registry).

41. Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

42. Dedicated two-stent technique in complex bifurcation percutaneous coronary intervention with use of everolimus-eluting stents: The EES-bifurcation study.

43. Impact of Major Bleeding on Long-Term Mortality in Anemic Versus Nonanemic Patients Undergoing Percutaneous Coronary Intervention Using Bivalirudin.

44. Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study.

45. GuideLiner Mother-and-Child Guide Catheter Extension: A Simple Adjunctive Tool in PCI for Balloon Uncrossable Chronic Total Occlusions.

46. Expression of angiotensin-converting enzyme 2 and its end product angiotensin 1-7 is increased in diabetic atheroma: implications for inflammation and neovascularization

47. Safety of temporary and permanent suspension of antiplatelet therapy after drug eluting stent implantation in contemporary "real-world" practice.

48. Safety of Temporary and Permanent Suspension of Antiplatelet Therapy After Drug Eluting Stent Implantation in Contemporary 'Real-world' Practice.

49. Inverse relationship between body mass index and coronary artery calcification in patients with clinically significant coronary lesions

50. Impact of the Everolimus-Eluting Stent on Stent Thrombosis: A Meta-Analysis of 13 Randomized Trials

Catalog

Books, media, physical & digital resources